Report Detail
Global Endometriosis Market Professional Survey Report 2019
- RnM3752061 |
- 16 September, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.
The global Endometriosis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Endometriosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Endometriosis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Endometriosis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Endometriosis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Segment by Application
Hospital Use
Clinic Use
Other
Table of Contents
Executive Summary
1 Industry Overview of Endometriosis
- 1.1 Definition of Endometriosis
- 1.2 Endometriosis Segment by Type
- 1.2.1 Global Endometriosis Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Gonadotropins Releasing Hormone Agonists
- 1.2.3 Non-Steroidal Anti-Inflammatory Drugs
- 1.2.4 Progestin
- 1.2.5 Oral Contraceptive Pills
- 1.3 Endometriosis Segment by Applications
- 1.3.1 Global Endometriosis Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Use
- 1.3.3 Clinic Use
- 1.3.4 Other
- 1.4 Global Endometriosis Overall Market
- 1.4.1 Global Endometriosis Revenue (2014-2025)
- 1.4.2 Global Endometriosis Production (2014-2025)
- 1.4.3 North America Endometriosis Status and Prospect (2014-2025)
- 1.4.4 Europe Endometriosis Status and Prospect (2014-2025)
- 1.4.5 China Endometriosis Status and Prospect (2014-2025)
- 1.4.6 Japan Endometriosis Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Endometriosis Status and Prospect (2014-2025)
- 1.4.8 India Endometriosis Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Endometriosis
- 2.3 Manufacturing Process Analysis of Endometriosis
- 2.4 Industry Chain Structure of Endometriosis
3 Development and Manufacturing Plants Analysis of Endometriosis
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Endometriosis Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Endometriosis
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Endometriosis Production and Capacity Analysis
- 4.2 Endometriosis Revenue Analysis
- 4.3 Endometriosis Price Analysis
- 4.4 Market Concentration Degree
5 Endometriosis Regional Market Analysis
- 5.1 Endometriosis Production by Regions
- 5.1.1 Global Endometriosis Production by Regions
- 5.1.2 Global Endometriosis Revenue by Regions
- 5.2 Endometriosis Consumption by Regions
- 5.3 North America Endometriosis Market Analysis
- 5.3.1 North America Endometriosis Production
- 5.3.2 North America Endometriosis Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Endometriosis Import and Export
- 5.4 Europe Endometriosis Market Analysis
- 5.4.1 Europe Endometriosis Production
- 5.4.2 Europe Endometriosis Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Endometriosis Import and Export
- 5.5 China Endometriosis Market Analysis
- 5.5.1 China Endometriosis Production
- 5.5.2 China Endometriosis Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Endometriosis Import and Export
- 5.6 Japan Endometriosis Market Analysis
- 5.6.1 Japan Endometriosis Production
- 5.6.2 Japan Endometriosis Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Endometriosis Import and Export
- 5.7 Southeast Asia Endometriosis Market Analysis
- 5.7.1 Southeast Asia Endometriosis Production
- 5.7.2 Southeast Asia Endometriosis Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Endometriosis Import and Export
- 5.8 India Endometriosis Market Analysis
- 5.8.1 India Endometriosis Production
- 5.8.2 India Endometriosis Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Endometriosis Import and Export
6 Endometriosis Segment Market Analysis (by Type)
- 6.1 Global Endometriosis Production by Type
- 6.2 Global Endometriosis Revenue by Type
- 6.3 Endometriosis Price by Type
7 Endometriosis Segment Market Analysis (by Application)
- 7.1 Global Endometriosis Consumption by Application
- 7.2 Global Endometriosis Consumption Market Share by Application (2014-2019)
8 Endometriosis Major Manufacturers Analysis
- 8.1 AbbVie
- 8.1.1 AbbVie Endometriosis Production Sites and Area Served
- 8.1.2 AbbVie Product Introduction, Application and Specification
- 8.1.3 AbbVie Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 AstraZeneca
- 8.2.1 AstraZeneca Endometriosis Production Sites and Area Served
- 8.2.2 AstraZeneca Product Introduction, Application and Specification
- 8.2.3 AstraZeneca Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Bayer HealthCare
- 8.3.1 Bayer HealthCare Endometriosis Production Sites and Area Served
- 8.3.2 Bayer HealthCare Product Introduction, Application and Specification
- 8.3.3 Bayer HealthCare Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Pfizer
- 8.4.1 Pfizer Endometriosis Production Sites and Area Served
- 8.4.2 Pfizer Product Introduction, Application and Specification
- 8.4.3 Pfizer Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Addex Therapeutics
- 8.5.1 Addex Therapeutics Endometriosis Production Sites and Area Served
- 8.5.2 Addex Therapeutics Product Introduction, Application and Specification
- 8.5.3 Addex Therapeutics Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Astellas Pharma
- 8.6.1 Astellas Pharma Endometriosis Production Sites and Area Served
- 8.6.2 Astellas Pharma Product Introduction, Application and Specification
- 8.6.3 Astellas Pharma Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Debiopharm
- 8.7.1 Debiopharm Endometriosis Production Sites and Area Served
- 8.7.2 Debiopharm Product Introduction, Application and Specification
- 8.7.3 Debiopharm Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 ElexoPharm
- 8.8.1 ElexoPharm Endometriosis Production Sites and Area Served
- 8.8.2 ElexoPharm Product Introduction, Application and Specification
- 8.8.3 ElexoPharm Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 EndoCeutics
- 8.9.1 EndoCeutics Endometriosis Production Sites and Area Served
- 8.9.2 EndoCeutics Product Introduction, Application and Specification
- 8.9.3 EndoCeutics Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Euroscreen
- 8.10.1 Euroscreen Endometriosis Production Sites and Area Served
- 8.10.2 Euroscreen Product Introduction, Application and Specification
- 8.10.3 Euroscreen Endometriosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Forendo Pharma
- 8.12 Kissei Pharmaceutical
- 8.13 Neurocrine Biosciences
- 8.14 Nippon Shinyaku
- 8.15 Takeda
- 8.16 Bayer AG
- 8.17 Neurocrine Biosciences
9 Development Trend of Analysis of Endometriosis Market
- 9.1 Global Endometriosis Market Trend Analysis
- 9.1.1 Global Endometriosis Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Endometriosis Regional Market Trend
- 9.2.1 North America Endometriosis Forecast 2019-2025
- 9.2.2 Europe Endometriosis Forecast 2019-2025
- 9.2.3 China Endometriosis Forecast 2019-2025
- 9.2.4 Japan Endometriosis Forecast 2019-2025
- 9.2.5 Southeast Asia Endometriosis Forecast 2019-2025
- 9.2.6 India Endometriosis Forecast 2019-2025
- 9.3 Endometriosis Market Trend (Product Type)
- 9.4 Endometriosis Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Endometriosis Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Endometriosis. Industry analysis & Market Report on Endometriosis is a syndicated market report, published as Global Endometriosis Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Endometriosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
